This study included 216 CCA patients and 233 healthy control subjects for genotyping, and showed that polymorphisms of NAT1*11 and NAT2 (NAT2*6B (rs1799930), 7A (rs1799931) and *13 reduced the risk of CCA (p < 0.006). The gene discussed is NAT1; the disease is cholangiocarcinoma.